Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycythemia Vera 6 Thrombocythemia, Essential 5 Carcinoma, Hepatocellular 4 Neoplasms 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Philadelphia Chromosome 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Leukemia 2 Hepatitis C, Chronic 2 Carcinoma, Squamous Cell 2 Skin Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neoplasm, Residual 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Influenza, Human 1 Infections 1 Hepatitis C 1 Hepatitis B, Chronic 1 Hemangiosarcoma 1 Colonic Neoplasms 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

Oxaliplatin 112 Fluorouracil 104 Leucovorin 91 Irinotecan 91 Capecitabine 59 Bevacizumab 58 Cetuximab 46 Folfox protocol 28 Colonoscopy 24 Panitumumab 19 Chemotherapy, Adjuvant 19 Blood Specimen Collection 19 Drug Therapy 18 Nivolumab 17 Magnetic Resonance Spectroscopy 17 Radiotherapy 16 Exercise 16 Early Intervention, Educational 16 Surveys and Questionnaires 15 Laparoscopy 15 Surgical Procedures, Operative 13 Floxuridine 13 Biopsy 13 trifluridine tipiracil drug combination 12 pembrolizumab 12 XELOX 12 Neoadjuvant Therapy 11 Methods 11 Immunohistochemistry 11 Celecoxib 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Colonic Neoplasms × peginterferon alfa-2a × Clear all

NCT04798612 2023-08-18

IPOS

Zealand University Hospital

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡